TIGERQ (private company)
See something wrong or missing? Let us know
Offices:Lund
Industry:
Biotech
Health services
Business model:
B2B
TIGERQ develops a sample-to-analysis solution, a state-of-the-art NGS pipeline, combined with proprietary analysis, for answers of the highest accuracy to all gene editing efficiency questions.
Investors:
we tracked 0 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 1.15m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom